Not yet recruitingObservationalUpdated Aug 7, 2026
Immunomodulation Effect of Regional Citrate Anticoagulation in Acute Kidney Injury Requiring Continuous Renal Replacement Therapy | NCT02423642 | Trialant
CompletedInterventionalNot ApplicableUpdated Mar 5, 2021
Immunomodulation Effect of Regional Citrate Anticoagulation in Acute Kidney Injury Requiring Continuous Renal Replacement Therapy
ClinicalTrials.gov ID
NCT02423642
Lead Sponsor
Chulalongkorn UniversityOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
30Actual
Last Update Posted
Mar 5, 2021Actual
Start Date
Jul 2013
Primary Completion Date
Nov 2014Actual
Completion Date
Nov 2014Actual
Brief Summary
The purpose of this study is to study the effect of anticoagulation in immune response with Acute Kidney Injury (AKI) undergoing Continuous Renal Replacement Therapy (CRRT).
Acute Kidney Injury
Continuous renal replacement therapy with regional citrate anticoagulation
Continuous renal replacement therapy with no anticoagulation or heparin